This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2014.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. NxStage Medical next reports earnings on July 21, 2014.
To receive a free e-mail notification whenever NxStage Medical makes a similar move, sign up!
Other recent filings from the company include the following:
NxStage Medical's SVP and General Counsel just disposed of 500 shares - Dec. 19, 2014
NxStage Medical's Chief Accounting Officer just disposed of 3,000 shares - Dec. 16, 2014
NxStage Medical's President just cashed-in 2,000 options - Dec. 16, 2014
NxStage Medical's President just disposed of 1,500 shares - Dec. 11, 2014
NxStage Medical's CEO just disposed of 5,000 shares - Dec. 8, 2014